← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

Director Shehnaaz Suliman sold $144K of Ultragenyx Pharmaceutical Inc.

Sold$144,189
$25.12Price
5,740Shares
−17%Stake

What RARE did after the filing

Filed May 18Copier in May 19
The stock from Tue, May 19 open, $24.20
+38.3%
S&P 500, same days
+1.4%

Measured over 30 trading days, to the Jul 2 close.

Traded Mon, May 18. Filed Mon, May 18, 6:41 PM ET, after the close. Returns use the May 19 open and the Jul 2 close. Not investment advice.